Ampiclox LC, intramammaarsuspensioon lakteerivatele lehmadele
Ampiclox LC, intramammaarsuspensioon lakteerivatele lehmadele
Authorised
- Ampicillin
- Cloxacillin
Product identification
Medicine name:
Ampiclox LC, intramammaarsuspensioon lakteerivatele lehmadele
Active substance:
- Ampicillin
- Cloxacillin
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Ampicillin75.00/milligram(s)1.00Syringe
-
Cloxacillin200.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (lactating cow)
-
Meat and offal7day
-
Milk60hourPiimale: 60 tundi. Kui lehmi lüpstakse kaks korda päevas, võib hakata piima inimtoiduks koguma siis, kui ravimi viimasest manustamisest on möödunud 60 tundi (st 5. lüpsikorral). Ka teiste lüpsirežiimide puhul peab veterinaararsti otsus piima inimtoiduks kogumise kohta põhinema samal perioodil viimasest ravimi manustamisest (näiteks kolm korda päevas lüpstes ja ravimit kaks korda päevas manustades võib piima inimtoiduks koguda alates 8. lüpsikorrast).
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC20
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- RAVIMIAMET
Authorisation number:
- 1385
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 20/01/2022
How useful was this page?:
